GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Veri Medtech Holdings Inc (OTCPK:VRHI) » Definitions » Net-Net Working Capital

VRHI (Veri Medtech Holdings) Net-Net Working Capital : $0.00 (As of Dec. 2021)


View and export this data going back to . Start your Free Trial

What is Veri Medtech Holdings Net-Net Working Capital?

In calculating the Net-Net Working Capital (NNWC), Benjamin Graham assumed that a company's accounts receivable is only worth 75% its value, its inventory is only worth 50% of its value, but its liabilities have to be paid in full. In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. This is a conservative way of estimating the company's value.

Veri Medtech Holdings's Net-Net Working Capital for the quarter that ended in Dec. 2021 was $0.00.

The industry rank for Veri Medtech Holdings's Net-Net Working Capital or its related term are showing as below:

VRHI's Price-to-Net-Net-Working-Capital is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 7.7
* Ranked among companies with meaningful Price-to-Net-Net-Working-Capital only.

Veri Medtech Holdings Net-Net Working Capital Historical Data

The historical data trend for Veri Medtech Holdings's Net-Net Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Veri Medtech Holdings Net-Net Working Capital Chart

Veri Medtech Holdings Annual Data
Trend Dec21
Net-Net Working Capital
-

Veri Medtech Holdings Semi-Annual Data
Dec21
Net-Net Working Capital -

Competitive Comparison of Veri Medtech Holdings's Net-Net Working Capital

For the Health Information Services subindustry, Veri Medtech Holdings's Price-to-Net-Net-Working-Capital, along with its competitors' market caps and Price-to-Net-Net-Working-Capital data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Veri Medtech Holdings's Price-to-Net-Net-Working-Capital Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Veri Medtech Holdings's Price-to-Net-Net-Working-Capital distribution charts can be found below:

* The bar in red indicates where Veri Medtech Holdings's Price-to-Net-Net-Working-Capital falls into.


;
;

Veri Medtech Holdings Net-Net Working Capital Calculation

Veri Medtech Holdings's Net-Net Working Capital (NNWC) per share for the fiscal year that ended in Dec. 2021 is calculated as

Net-Net Working Capital(A: Dec. 2021 )
=(Cash, Cash Equivalents, Marketable Securities+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(0.185+0.75 * 0+0.5 * 0-0.272
-0-0)/0
=N/A

Veri Medtech Holdings's Net-Net Working Capital (NNWC) per share for the quarter that ended in Dec. 2021 is calculated as

Net-Net Working Capital(Q: Dec. 2021 )
=(Cash, Cash Equivalents, Marketable Securities+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(0.185+0.75 * 0+0.5 * 0-0.272
-0-0)/0
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In calculating the Net-Net Working Capital (NNWC), Benjamin Graham assumed that a company's accounts receivable is only worth 75% its value, its inventory is only worth 50% of its value, but its liabilities have to be paid in full.

In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. In "Security Analysis", preferred stock is dubbed "an imperfect creditorship position" that is best placed on the balance sheet alongside funded debt.

This is a conservative way of estimating the company's value.


Veri Medtech Holdings  (OTCPK:VRHI) Net-Net Working Capital Explanation

One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham's strategy produced similar results.

Benjamin Graham looked for companies whose market values were less than two-thirds of their net-net value. They are collected under our Net-Net screener.


Veri Medtech Holdings Net-Net Working Capital Related Terms

Thank you for viewing the detailed overview of Veri Medtech Holdings's Net-Net Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


Veri Medtech Holdings Business Description

Traded in Other Exchanges
N/A
Address
1660 International Dr, Suite 600, McClean, VA, USA, 22101
Veri Medtech Holdings Inc is a healthcare technology company that offers alternative medicine, personalized diagnostics, and wellness medication on demand. The company leverages telehealth infrastructure, diagnostic intelligence, and scalable digital systems to meet the growing demand for accessible, stigma-free healthcare. Strategically positioned for growth, Veri MedTech actively explores acquisitions that complement its core capabilities and enhance patient engagement across emerging sectors of alternative medicine, longevity, and wellness science. With a integration and operational efficiency track record, the company drives accelerated revenue through the continuous generation of high-value patient databases and recurring service models.

Veri Medtech Holdings Headlines